comparemela.com

Latest Breaking News On - ரிக்கார்டோ பாழசிோஸ் - Page 10 : comparemela.com

Turkey s COVID vaccination plan depends entirely on a Chinese vaccine with mixed trial results

Turkey s COVID vaccination plan depends entirely on a Chinese vaccine with mixed trial results By Pinar Sevinclidir Turkey s COVID fight relying on Chinese vaccine Istanbul  Turkey launched its mass-vaccination program against the coronavirus disease with the goal of first inoculating 1 million health workers. The program is relying entirely on the country s purchase of 50 million doses of a vaccine developed by the Chinese pharmaceutical company Sinovac. The success of Turkey s inoculation program could be a major international win for China s efforts at vaccine-based diplomacy, but initial optimism has been overshadowed by concerns over the vaccine s efficacy. Three Phase 3 human trials in three different countries yielded wildly different results, with one putting the efficacy of the jab at just 50.4% barely above the threshold set by the World Health Organization as acceptable for vaccines.

Brazil weighs COVID-19 vaccines as its death toll climbs

Brazil weighs COVID-19 vaccines as its death toll climbs ​​​​​​​Brazil’s health regulatory agency Anvisa has yet to approve a vaccine, but the directors are expected to meet this Sunday to vote on both the CoronaVac and AstraZeneca vaccines. Listen to the story. Amazonas Federal University s workers carry empty oxygen tanks at the Getulio Vargas Hospital amid the new coronavirus pandemic, Manaus, Brazil, Thursday, Jan. 14, 2021. Scores of COVID-19 patients in the Amazon rainforest s biggest city will be transferred out of state as the local health system collapses and dwindling stocks of oxygen tanks begin to falter. Credit: Share Brazilian army general and Health Minister Eduardo Pazuello told Brazilian mayors in a meeting Thursday that his government plans to begin vaccinating people on Jan. 20, if the CoronaVac and AstraZeneca vaccines are approved by then.

China Declares Its 50% Effective Coronavirus Vaccine Candidate Good Enough

China’s state-run Global Times on Wednesday put the happiest possible spin on a dismaying Brazilian study that showed China’s Sinovac vaccine candidate for the Chinese coronavirus is only 50 percent effective. Even though the results were far below the 80 percent effectiveness originally claimed and that, in turn, was far below the estimates for vaccines like the one made by Pfizer the Global Times declared it was “good enough.” Sao Paulo-based Instituto Butantan, the research institute developing the Sinovac product for distribution in Brazil, announced last week that clinical tests showed it to be 78 percent effective overall. On Tuesday, the institute revealed at a press conference that late-stage trials involving over 12,000 volunteers showed it was only 50.38 percent effective overall, although the Brazilian researchers said it was much more effective at treating “severe” cases of Chinese coronavirus than mild infections.

China s Sinovac vaccine trial results far less effective than initially claimed in Brazil

China s Sinovac vaccine trial results far less effective than initially claimed in Brazil
cnn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnn.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.